Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Translational Medicine|October 26, 2014
Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNFα in rheumatoid arthritisAdrian Richard Moore, Sarah Allden, Tim Bourne, et al.American Journal of Respiratory and Critical Care Medicine|June 9, 2018
Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic AsthmaDaniel Lightwood, Markus Tservistas, Monique Zehentleitner, et al.Mabs|March 28, 2014
Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signalingStevan Shaw, Tim Bourne, Chris Meier, et al.Nature Communications|January 26, 2021
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNFDaniel J Lightwood, Rebecca J Munro, John Porter, et al.Journal of Molecular Biology|December 11, 2012
The discovery, engineering and characterisation of a highly potent anti-human IL-13 fab fragment designed for administration by inhalationDaniel Lightwood, Victoria O'Dowd, Bruce Carrington, et al.Nature Communications|December 21, 2019
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimerJames O'Connell, John Porter, Boris Kroeplien, et al.JCI Insight|March 13, 2020
Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutationEmmanuel Martin, Norbert Minet, Anne-Claire Boschat, et al.Frontiers in Pharmacology|December 5, 2022
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritisAlexander Vugler, James O'Connell, Mai Anh Nguyen, et al.Frontiers in Pharmacology|October 31, 2024
Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritisAlexander Vugler, James O'connell, Mai Anh Nguyen, et al.Immunity|November 12, 2021
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and functionAyaka Sugiura, Gabriela Andrejeva, Kelsey Voss, et al.Pageof 2